Ten-Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice.
Xiaoxi YaoHolly K Van HoutenKonstantinos C SiontisM P H Paul A FriedmanRobert D McBane IiBernard J GershPeter A NoseworthyPublished in: Journal of the American Heart Association (2024)
The use of and adherence to OAC were higher in non-POAF patients than in POAF patients, but they increased over time in both groups. Patients managed by cardiologists were more likely to use and adhere to OAC, regardless of POAF or non-POAF.
Keyphrases
- end stage renal disease
- atrial fibrillation
- newly diagnosed
- ejection fraction
- chronic kidney disease
- clinical practice
- peritoneal dialysis
- prognostic factors
- heart failure
- type diabetes
- patient reported outcomes
- metabolic syndrome
- patients undergoing
- venous thromboembolism
- coronary artery disease
- weight loss
- left ventricular